NIPH Clinical Trials Search

Basic Information

Recruitment status
Health condition(s) or Problem(s) studied	Prophylaxis of new type of influenza infection
Date of first enrollment	16/07/2013
Target sample size	30
Countries of recruitment
Study type	Interventional
Intervention(s)	investigational material(s) Generic name etc : KIB-PCI INN of investigational material : Therapeutic category code : 631 Vaccines Dosage and Administration for Investigational material : intramuscular

Outcome(s)

Primary Outcome	SRH antibody titer
Secondary Outcome	HI antibody titer Neutralizing antibody titer

Key inclusion & exclusion criteria

Age minimum	Not applicable
Age maximum	Not applicable
Gender	Both
Include criteria	1) healthy Japanese children
Exclude criteria	1) Subjects with history of H5N1 influenza 2) Subjects with history of H5N1 influenza vaccination